Understanding what happens physiologically when you discontinue semaglutide helps you make informed decisions about your weight management journey
This innovative GLP-1 receptor agonist has shown promising effects on metabolic health, making it a key player in managing liver-related conditions such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
Re-testing labs at structured points tells us whether the strategy is moving the metabolic markers we care about
Seek medical advice if you experience persistent pain in the upper right abdomen, fever, or yellowing of the skin or eyes
In this episode, I break down the surprising math behind GLP-1 medications, food noise, grocery spending, takeout habits, and weight loss costs
CANVAS Trial Collaborative Group